Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Leukemia, Myeloid, Acute
Clinical trial register · Spain

Leukemia, Myeloid, Acute Trials in Spain, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5882 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
5882
Studies in scope
all four open statuses
3093
Recruiting now
open to new participants
1126
Lead sponsors
across recruiting studies
Top sites
Barcelona 9 Madrid 8 Pamplona 5 Salamanca 4 Valencia 4

Leukemia, Myeloid, Acute trials in Spain

11 of 5882 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
600
A Coruña, Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón
2025-06-04
Active, closed
Janssen Research & Development, LLC
Phase 1
85
Madrid, Pamplona, Seville
2025-03-21
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
Janssen Research & Development, LLC
Phase 1
120
Barcelona, Madrid, Pamplona, Salamanca
2024-12-30
Active, closed
OncoVerity, Inc.
Phase 2
140
Barcelona, Pamplona, Salamanca
2024-07-22
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Barcelona, Madrid, Pamplona
2022-10-04
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
Sumitomo Pharma America, Inc.
Phase 1/2
606
Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander
2022-02-28
Active, closed
PETHEMA Foundation
Phase 3
302
Santiago de Compostela, Vitoria-Gasteiz, Badalona, Hospitalet Del Llobregat, San Sebastián, Jaén, Las Palmas de Gran Canaria, Pozuelo de Alarcón
2019-09-24
Active, closed
OncoVerity, Inc.
Phase 2
103
Pozuelo de Alarcón, Barcelona, Córdoba, Madrid, Palma, Salamanca, Valencia
2019-07-29
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Barcelona, Pozuelo de Alarcón, Oviedo, Valencia
2019-03-11
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
Institut de Recherches Internationales Servier
Phase 3
146
Santiago de Compostela, Palma de Mallorca, Badalona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville, Valencia
2017-06-26
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-spain/condition/leukemia-myeloid-acute

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,882 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Leukemia, Myeloid, Acute.

How many Leukemia, Myeloid, Acute trials are recruiting in Spain?

3 of the 11 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Leukemia, Myeloid, Acute), 11 studies
PhaseStudiesRecruitingShare
Phase 13027.3%
Phase 1/23227.3%
Phase 33127.3%
Phase 22018.2%

Most active sponsors

Lead sponsors with the most studies (Leukemia, Myeloid, Acute)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC41
OncoVerity, Inc.20
Aptose Biosciences Inc.11
Celgene10
Institut de Recherches Internationales Servier10
PETHEMA Foundation10
Sumitomo Pharma America, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.